FreeTCCL Archive Study: Gene Assay Can Provide Valid Prognostic Information February 03, 2014Vol.37 No.01
FreeTCCL Archive Post-Hoc Analysis of ThermoDox Suggests OS Improvement February 03, 2014Vol.37 No.01
FreeTCCL Archive Patients on Hypertension Medications Lived Longer, Analysis Shows February 03, 2014Vol.37 No.01
FreeTCCL Archive Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk February 03, 2014Vol.37 No.01
FreeTCCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival February 03, 2014Vol.37 No.01
FreeTCCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial February 03, 2014Vol.37 No.01
TCCL Archive Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival December 27, 2013Vol.36 No.12
TCCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013Vol.36 No.12
TCCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013Vol.36 No.12
